T-lymphocyte subsets in primary lung cancer

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Lung cancer is a leading cause of cancer-related mortality.
• T-lymphocyte subsets play a critical role in immune surveillance and response to cancer.
• Alterations in T-cell populations may indicate disease progression or immune evasion.

Purpose of the Study:

• To investigate T-cell subset profiles in patients with primary lung cancer.
• To correlate T-lymphocyte subset levels with lung cancer cell types and disease stages.
• To assess the immunoregulatory balance using the OKT4/OKT8 ratio in lung cancer.

Main Methods:

• Peripheral blood T-cell subsets (OKT3, OKT4, OKT8) were analyzed using indirect immunofluorescence.
• Sixty-three primary lung cancer patients (adenocarcinoma, squamous cell carcinoma, small cell carcinoma) and 24 healthy controls were studied.
• Statistical analysis was performed to correlate T-cell subset percentages and ratios with disease stage and histology.

Main Results:

• Total lymphocytes were decreased in lung cancer patients.
• The percentage of OKT8-positive (cytotoxic/suppressor) T-cells increased in early disease stages.
• The OKT4/OKT8 ratio was significantly decreased in early-stage lung cancer (Stage I-II), especially in squamous cell carcinoma, and in Stage III small cell carcinoma.

Conclusions:

• Early-stage lung cancer, particularly squamous cell carcinoma, is associated with a decreased OKT4/T8 ratio, suggesting an impaired immune regulatory balance.
• The T-cell subset profile, specifically the OKT4/T8 ratio, shows dynamic changes with disease progression and may differ between lung cancer subtypes.
• Further research into T-cell modulation could offer novel therapeutic strategies for lung cancer.